Latest Ratios: P/E Ratio 171.2x · EV/EBITDA 24.2x · ROE 5.8%. (2015–2026 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $4.5B | $3.6B | $3.7B | $11.3B | $4.6B | $1.4B | $1.4B | $500M | $427M | $1.1B | $1.5B |
| Enterprise Value | $5.1B | $4.2B | $3.8B | $11.5B | $4.5B | $1.5B | $1.5B | $607M | $526M | $1.2B | $1.6B |
| P/E Ratio → | 171.23 | 137.75 | 32.70 | 88.70 | 74.19 | 63.00 | 223.58 | 28.11 | 27.06 | 32.81 | 263.09 |
| P/S Ratio | 2.74 | 2.20 | 2.79 | 11.06 | 7.87 | 3.53 | 4.39 | 1.77 | 1.60 | 4.08 | 6.34 |
| P/B Ratio | 3.96 | 3.18 | 4.81 | 17.63 | 11.09 | 4.44 | 5.17 | 2.06 | 1.86 | 5.68 | 10.34 |
| P/FCF | 23.56 | 18.93 | 31.77 | 181.27 | 45.50 | 94.31 | 60.65 | 14.33 | 9.13 | 227.88 | — |
| P/OCF | 21.07 | 16.93 | 27.37 | 159.21 | 44.73 | 71.02 | 47.33 | 11.28 | 7.68 | 88.99 | 686.74 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 2.58 | 2.91 | 11.24 | 7.81 | 3.72 | 4.68 | 2.15 | 1.97 | 4.62 | 6.99 |
| EV / EBITDA | 24.24 | 20.06 | 18.94 | 64.00 | 52.70 | 25.67 | 43.04 | 11.49 | 11.94 | 26.11 | 44.31 |
| EV / EBIT | 38.89 | 52.00 | 23.61 | 75.53 | 66.72 | 52.99 | 214.49 | 19.90 | 21.02 | 41.00 | 72.72 |
| EV / FCF | — | 22.23 | 33.19 | 184.19 | 45.11 | 99.32 | 64.70 | 17.39 | 11.26 | 258.14 | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 70.7% | 70.7% | 71.2% | 70.7% | 67.4% | 64.2% | 64.8% | 64.0% | 60.9% | 61.0% | 57.6% |
| Operating Margin | 8.0% | 8.0% | 12.0% | 14.6% | 11.8% | 7.6% | 3.0% | 10.6% | 9.8% | 12.3% | 10.1% |
| Net Profit Margin | 3.3% | 3.3% | 8.5% | 12.5% | 10.6% | 5.6% | 2.0% | 6.3% | 5.8% | 12.4% | 2.3% |
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 5.8% | 5.8% | 16.0% | 24.2% | 17.0% | 7.5% | 2.4% | 7.6% | 7.3% | 20.0% | 3.8% |
| ROA | 3.0% | 3.0% | 9.4% | 14.8% | 11.3% | 4.4% | 1.3% | 4.0% | 3.6% | 8.0% | 1.4% |
| ROIC | 7.3% | 7.3% | 13.5% | 18.8% | 13.5% | 6.0% | 2.0% | 6.6% | 5.9% | 7.9% | 6.2% |
| ROCE | 8.4% | 8.4% | 16.6% | 22.7% | 14.9% | 7.1% | 2.3% | 7.5% | 6.9% | 9.5% | 7.1% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.81 | 0.81 | 0.41 | 0.45 | 0.20 | 0.37 | 0.56 | 0.63 | 0.66 | 0.81 | 1.17 |
| Debt / EBITDA | 4.35 | 4.35 | 1.55 | 1.62 | 0.96 | 2.06 | 4.36 | 2.90 | 3.42 | 3.27 | 4.55 |
| Net Debt / Equity | — | 0.55 | 0.22 | 0.28 | -0.09 | 0.24 | 0.35 | 0.44 | 0.43 | 0.75 | 1.06 |
| Net Debt / EBITDA | 2.98 | 2.98 | 0.81 | 1.01 | -0.45 | 1.30 | 2.69 | 2.02 | 2.25 | 3.06 | 4.13 |
| Debt / FCF | — | 3.30 | 1.42 | 2.92 | -0.39 | 5.01 | 4.05 | 3.06 | 2.12 | 30.26 | — |
| Interest Coverage | 1.99 | 1.99 | 9.44 | 12.87 | 16.97 | 11.27 | 1.69 | 4.83 | 3.20 | 3.82 | 1.80 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.35 | 2.35 | 3.05 | 1.59 | 2.81 | 2.97 | 2.32 | 2.59 | 3.30 | 2.41 | 1.56 |
| Quick Ratio | 1.69 | 1.69 | 2.00 | 0.95 | 2.06 | 1.67 | 1.55 | 1.69 | 2.22 | 1.19 | 0.69 |
| Cash Ratio | 0.86 | 0.86 | 0.84 | 0.36 | 1.12 | 0.67 | 0.79 | 0.90 | 1.19 | 0.20 | 0.19 |
| Asset Turnover | — | 0.68 | 1.05 | 0.91 | 0.97 | 0.79 | 0.65 | 0.62 | 0.61 | 0.65 | 0.55 |
| Inventory Turnover | 2.18 | 2.18 | 2.02 | 1.57 | 2.32 | 1.66 | 1.97 | 2.20 | 2.26 | 1.68 | 1.40 |
| Days Sales Outstanding | — | 38.95 | 35.02 | 44.13 | 42.83 | 42.41 | 46.11 | 38.35 | 50.12 | 60.36 | 60.14 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | 4.7% |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 0.6% | 0.7% | 3.1% | 1.1% | 1.3% | 1.6% | 0.4% | 3.6% | 3.7% | 3.0% | 0.4% |
| FCF Yield | 4.2% | 5.3% | 3.1% | 0.6% | 2.2% | 1.1% | 1.6% | 7.0% | 10.9% | 0.4% | — |
| Buyback Yield | 1.1% | 1.4% | 1.8% | 0.0% | 0.0% | 0.0% | 0.0% | 1.6% | 0.0% | 0.0% | 12.2% |
| Total Shareholder Yield | 1.1% | 1.4% | 1.8% | 0.0% | 0.0% | 0.0% | 0.0% | 1.6% | 0.0% | 0.0% | 16.9% |
| Shares Outstanding | — | $59M | $58M | $58M | $55M | $54M | $52M | $51M | $49M | $49M | $50M |
High Marketing Spend Dependency
Based on current market data, the company's forward P/E of 20.43 and PEG ratio of 5.16 suggest that investors are pricing in significant future growth, which appears increasingly difficult to justify given the recent deceleration in top-line expansion and the volatility in bottom-line profitability metrics.
The valuation multiples indicate a market expectation for sustained high-growth, yet the PEG ratio exceeding 5.0 signals that the current price may be disconnected from the underlying earnings trajectory. Investors should monitor whether the company can transition from a growth-at-any-cost model to one that demonstrates consistent margin expansion, as the current premium leaves little room for execution errors.
As reported in financial statements, the company's ROIC has struggled to maintain momentum, falling to 0.3% in 2026Q4 from a peak of 4.4% in 2025Q1, which highlights a concerning trend of declining returns on invested capital as the firm scales its asset base through acquisitions.
The compression in ROIC suggests that the capital deployed for recent acquisitions and infrastructure expansion is not yet generating commensurate returns. This trend warrants further investigation into whether the company's core business model is losing its inherent efficiency or if the recent capital allocation strategy is simply taking longer than anticipated to reach maturity.
According to recent quarterly filings, the cash conversion cycle has expanded to 135 days in 2026Q4, driven largely by a bloated inventory position of 162 days, which suggests that the company's fast-beauty model is facing significant friction in managing its supply chain and inventory turnover.
The lengthening of the cash conversion cycle indicates that capital is increasingly trapped in inventory, which may be a byproduct of aggressive product launches or slowing demand for specific SKUs. This inefficiency is particularly concerning given the company's reliance on third-party manufacturing, as it suggests a potential mismatch between production cadence and actual retail sell-through.
Based on the company's reported figures, the current ratio of 2.35 in 2026Q4 provides a superficial sense of security, yet the quick ratio of 1.69 reveals a heavy dependence on inventory liquidity, which may be problematic if market trends shift and necessitate significant inventory write-downs.
While the liquidity position appears adequate on the surface, the reliance on inventory to meet short-term obligations is a structural vulnerability for a trend-driven business. Investors should monitor the quality of this inventory, as any failure to clear stock at full price could rapidly erode the company's liquidity buffer and force a reliance on external financing.
The P/E ratio is frequently misapplied to this business model because it fails to account for the massive, non-cash stock-based compensation expenses that artificially depress net income, thereby obscuring the company's true operational earning power and cash-generating capacity in the eyes of many retail investors.
Analysts should instead prioritize EV/EBITDA or free cash flow metrics to better understand the company's underlying performance, as these measures are less distorted by accounting choices and non-cash charges. Relying on P/E in this context risks misinterpreting the company's profitability, as it ignores the significant economic cost of the equity-based incentives used to drive the firm's growth strategy.
Includes 30+ ratios · 12 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying ELF stock.
e.l.f. Beauty, Inc.'s current P/E ratio is 171.2x. The historical average is 60.5x. This places it at the 100th percentile of its historical range.
e.l.f. Beauty, Inc.'s current EV/EBITDA is 24.2x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 31.8x.
e.l.f. Beauty, Inc.'s return on equity (ROE) is 5.8%. The historical average is 8.3%.
Based on historical data, e.l.f. Beauty, Inc. is trading at a P/E of 171.2x. This is at the 100th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
e.l.f. Beauty, Inc. has 70.7% gross margin and 8.0% operating margin.
e.l.f. Beauty, Inc.'s Debt/EBITDA ratio is 4.4x, indicating high leverage. A ratio above 4x may signal elevated financial risk.